Management of Copper Deficiency in Cholestatic Infants: Review of the Literature and a Case Series

1Department of Pharmacy Services/College of Pharmacy, University of Michigan, Ann Arbor.
Nutrition in Clinical Practice (Impact Factor: 2.4). 10/2012; 28(1). DOI: 10.1177/0884533612461531
Source: PubMed


Copper is an essential trace element, playing a critical role in multiple functions in the body. Despite the necessity of adequate copper provision and data supporting the safety of copper administration during cholestasis, it remains common practice to reduce or remove copper in parenteral nutrition (PN) solutions after the development of cholestasis due to historical recommendations supporting this practice. In neonates, specifically premature infants, less is known about required copper intakes to accumulate copper stores and meet increased demands during rapid growth. Pediatric surgical patients are at high risk for hepatic injury during long-term PN provision and a balance is needed between the potential for reduced biliary excretion of copper and adequate copper intakes to prevent deficiency. Copper deficiency has been documented in several pediatric patients with cholestasis when parenteral copper was reduced or removed. Few data guide the management of copper deficiency in the pediatric population. The following case series describes our experience with successfully managing copper deficiency in 3 cholestatic infants after copper had been reduced or removed from their PN. Classic signs of copper deficiency were present, including hypocupremia, anemia, neutropenia, thrombocytopenia, and osteopenia. Treatment included use of both parenteral and enteral copper supplementation. We suggest revision of current recommendations regarding decreasing copper in PN during cholestasis with a proposed algorithm for parenteral copper provision in the setting of cholestasis that is based on evaluation of measured serum copper concentrations.

Full-text preview

Available from:
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A recent review of macronutrients in parenteral nutrition (PN) in the NICU population summarized the carbohydrate, protein, and fat nutrients in PN.1 The purpose of this article is to review the other nutrients in PN that are important for growth and homeostasis including minerals or electrolytes, vitamins, and trace elements. Although the macronutrients contribute more dramatically to adequate nutrition and growth, the other components in PN have significant impact on use of macronutrients as well as targeted organ and cellular function.
    Full-text · Article · May 2014 · Neonatal network: NN
  • [Show abstract] [Hide abstract]
    ABSTRACT: The liver is an incredibly complex organ. It performs more than 500 metabolic functions, many of which are related to nutrition (Table 1). I never cease to be amazed at how nutrition and the liver are closely intertwinedhow one can be the cause of deficiencies in the other, or how improvements in one condition improve conditions in the other. Extremes of nutrition status (ie, malnutrition or obesity) can cause liver dysfunction. On the other hand, liver dysfunction can cause nutrient deficiencies, and nutrients can either cause or treat liver disease. The aim of this Commentary is to explore some of the interrelations and complex connections between nutrition and liver disease and set the stage for this issue of Nutrition in Clinical Practice (NCP).
    No preview · Article · Feb 2013 · Nutrition in Clinical Practice
  • [Show abstract] [Hide abstract]
    ABSTRACT: Parenteral nutrition (PN) has revolutionized the nutritional care of patients who cannot fully use the gastrointestinal tract. Today more than 30,000 patients, young and old, depend on long-term PN for survival, and more than 350,000 patients in the USA receive PN on a yearly basis. Despite its common usage, PN is associated with a number of significant morbidities. Parenteral nutrition-associated liver disease (PNALD) has become one of the most challenging complications associated with prolonged administration of PN. As PNALD progresses to a more permanent injury to the liver, patients are at high risk of additional morbidity and even mortality. A number of recognized risk factors have been attributed to PNALD, but it appears that no single factor is fully responsible as a causative agent or factor. Thus, the multifactorial nature of PNALD has been an incredible challenge to both clinicians and researchers, and the process unfortunately remains incompletely understood. This chapter discusses the current knowledge of PNALD, the potential causative factors, as well as treatment and preventive strategies. © 2014 Springer Science+Business Media New York. All rights reserved.
    No preview · Chapter · Jan 2014
Show more